The Silent Pandemic: How COVID-19’s Shadow Continues to Claim Lives
There’s a chilling irony in the way we’ve framed the COVID-19 pandemic. We’ve fixated on the immediate toll—the ventilators, the lockdowns, the daily death counts. But what’s far less visible, and arguably more insidious, is the way the pandemic has reshaped the trajectory of countless lives by delaying diagnoses for diseases like cancer. Personally, I think this is one of the most underreported legacies of the pandemic. It’s not just about the numbers; it’s about the stories behind those numbers—stories of people whose lives were irrevocably altered because they missed a routine check-up or hesitated to seek care.
The Hidden Toll of Delayed Diagnoses
Let’s start with the facts, though I’ll keep them brief because, in my opinion, the real story lies in what these numbers imply. A study in The Lancet Oncology revealed that over 55,000 cancer cases went undiagnosed in seven countries during the first nine months of the pandemic. In Australia alone, 3,740 cases were missed. What makes this particularly fascinating is how these delays weren’t just about overwhelmed hospitals—though that was part of it. Many people avoided medical care out of fear of burdening the system or contracting COVID-19. From my perspective, this speaks to a broader psychological shift during the pandemic: a collective prioritization of survival over long-term health.
Take melanoma and rectal cancer, for example. In Australia, diagnoses for these cancers dropped by 11% and 10%, respectively. What many people don’t realize is that these aren’t just statistics—they represent thousands of individuals whose cancers progressed unchecked. One thing that immediately stands out is the ripple effect of these delays. As Melbourne oncologist Dr. Cameron McLaren pointed out, late-stage diagnoses mean more invasive treatments and higher recurrence rates. If you take a step back and think about it, this isn’t just a medical issue; it’s a societal one. We’re looking at years, if not decades, of increased healthcare costs and reduced quality of life for survivors.
The Echoing Waves of Recurrent Cancers
Here’s where it gets even more unsettling: the pandemic’s impact on cancer isn’t a one-time event. It’s a wave that keeps crashing. Oncologists are bracing for multiple waves of recurrent cancers as a direct result of delayed diagnoses. What this really suggests is that the pandemic’s health consequences are far from over. We’re only beginning to understand the long-term implications, and frankly, it’s terrifying.
A detail that I find especially interesting is the role of patient psychology in all this. Professor Sue Evans noted that many people delayed check-ups because they didn’t want to be a burden. This raises a deeper question: How did we create a healthcare system where people feel guilty for seeking care? In my opinion, this is a systemic failure that predates the pandemic but was exacerbated by it.
Personal Stories That Demand Our Attention
Numbers only tell part of the story. The human cost becomes clearer when you hear stories like Cheryl Priest’s. Before the pandemic, she was diligent about her annual blood tests. But she skipped two during the lockdowns. By the time she sought help, she was diagnosed with pancreatic and lung cancer. She’s now in remission, but the physical and mental scars remain. What’s striking to me is how easily her story could have been different. If she’d had those tests, her cancer might have been caught earlier, and her treatment less grueling.
Then there’s the case of the patient treated by Professor Declan Murphy, whose prostate-specific antigen (PSA) levels skyrocketed from 5.1 in 2019 to 60 in 2023. This isn’t just a medical anomaly; it’s a stark reminder of how quickly cancer can progress when left unchecked. In a parallel universe, as Murphy put it, this patient might have had a curable diagnosis. Instead, he’s facing advanced cancer with slim chances of survival.
The Broader Implications: A System in Crisis
If there’s one thing this crisis has laid bare, it’s the fragility of our healthcare systems. The pandemic didn’t create these issues, but it amplified them. We’ve known for years that early detection is key to cancer survival, yet we’ve built a system that crumbles under pressure. What this really suggests is that we need a fundamental rethink of how we approach healthcare.
From my perspective, the pandemic has forced us to confront uncomfortable truths. We’ve prioritized acute care over preventive measures, and we’ve failed to address the psychological barriers that keep people from seeking help. Luc te Marvelde, head of data analytics at the Victorian Cancer Registry, believes we still haven’t caught up with the “missing” cases. This isn’t just a problem for Australia; it’s a global issue.
Where Do We Go From Here?
As we move forward, I think the key question is: What are we willing to change? Do we continue to treat healthcare as a reactive system, or do we invest in prevention and early detection? Personally, I believe the latter is non-negotiable. We need to rebuild trust in healthcare systems, reduce barriers to access, and prioritize public health education.
But here’s the thing: change won’t happen overnight. It requires a shift in mindset—both at the individual and systemic levels. We need to stop seeing healthcare as a burden and start seeing it as a right. And we need to recognize that the pandemic’s shadow will linger for years, if not decades.
In the end, the story of missed cancer diagnoses isn’t just about the pandemic. It’s about the choices we make as a society. Will we learn from this, or will we repeat the same mistakes? That’s the question we all need to grapple with.
